Zafar Ahmad, MD
Adult Reconstructive Orthopaedic Surgery · Lewiston, MENPI 1750161782
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $9,026 of the $13,617 with a category attached, or 66.3%. 11 manufacturers reported payments, led by Stryker at 44.3% of the total. Reporting peaked in 2024 at $7,136 and has fallen 86.6% since, to $953 in 2025.
Across 104 payments — averaging $130.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$6K
- Zimmer Biomet$5K
- Medical Device Business Services, Inc.$2K
- Smith+Nephew$527
- Kairos Surgical Inc$252
- Encore Medical, LP$116
- plus $167 from 5 others
What the payments were for
- Grants$1,79513%
- Travel & lodging$9,02666%
- Food & beverage$2,68820%
- Education$1071%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 52 | $6,026 |
| Zimmer Biomet | 25 | $4,964 |
| Medical Device Business Services, Inc. | 11 | $1,565 |
| Smith+Nephew | 6 | $527 |
| Kairos Surgical Inc | 4 | $252 |
| Encore Medical, LP | 1 | $116 |
| Johnson & Johnson | 1 | $78 |
| Linkbio Corp | 1 | $41 |
| Integra Lifesciences Corporation | 1 | $19 |
| Orthofix Medical, Inc. | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few adult reconstructive orthopaedic surgery providers in Maineto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 13 | $55 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Lewiston
- Stephen WalshBangor$745K
- Brian McGroryFalmouth$424K
- Michael RobertsFalmouth$56K
- Joseph YoungFalmouth$16K
- Justin KuetherFalmouth$10K
- Michael DefranceAuburn$8K
- Megan RichardsBangor$4K
- Brigham McKenneySouth Portland$3K
- Donald EndrizziFalmouth$107
- Michael BeckerFalmouth$90
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.